Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)
Introduction: Baseline severity and clinical stroke syndrome (Oxford Community Stroke Project, OCSP) classification are predictors of outcome in stroke. We used data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’ (TAIST) to assess the relationship between stroke severity, early recovery, outc...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Elsevier
2007
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/675/ |
| _version_ | 1848790460712091648 |
|---|---|
| author | Sprigg, Nikola Gray, Laura J. Bath, Philip M.W. Lindenstrom, Ewa Boysen, Gudrun De Deyn, Peter Paul Friis, Pal Leys, Didier Marttila, Reijo Olsson, Jan-Edwin O'Neill, Desmond Ringelstein, Bernd |
| author_facet | Sprigg, Nikola Gray, Laura J. Bath, Philip M.W. Lindenstrom, Ewa Boysen, Gudrun De Deyn, Peter Paul Friis, Pal Leys, Didier Marttila, Reijo Olsson, Jan-Edwin O'Neill, Desmond Ringelstein, Bernd |
| author_sort | Sprigg, Nikola |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | Introduction: Baseline severity and clinical stroke syndrome (Oxford Community Stroke Project, OCSP) classification are predictors of outcome in stroke. We used data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’ (TAIST) to assess the relationship between stroke severity, early recovery, outcome and OCSP syndrome. Methods: TAIST was a randomised controlled trial assessing the safety and efficacy of tinzaparin versus aspirin in 1,484 patients with acute ischaemic stroke. Severity was measured as the Scandinavian Neurological Stroke Scale (SNSS) at baseline and days 4, 7 and 10, and baseline OCSP clinical classification recorded: total anterior circulation infarct (TACI), partial anterior circulation infarct (PACI), lacunar infarct (LACI) and posterior circulation infarction (POCI). Recovery was calculated as change in SNSS from baseline at day 4 and 10. The relationship between stroke syndrome
and SNSS at days 4 and 10, and outcome (modified Rankin scale at 90 days) were assessed.
Results: Stroke severity was significantly different between TACI (most severe) and LACI (mildest) at all four time points (p<0.001), with no difference between PACI and
POCI. The largest change in SNSS score occurred between baseline and day 4; improvement was least in TACI (median 2 units), compared to other groups (median 3 units) (p<0.001). If SNSS did not improve by day 4, then early recovery and late functional outcome tended to be limited irrespective of clinical syndrome (SNSS, baseline: 31, day 10: 32; mRS, day 90: 4); patients who recovered early tended to continue to improve and had better functional outcome irrespective of syndrome (SNSS, baseline: 35, day 10: 50; mRS, day 90: 2).
Conclusions: Although functional outcome is related to baseline clinical syndrome (best with LACI, worst with TACI), patients who improve early have a more favourable
functional outcome, irrespective of their OCSP syndrome. Hence, patients with a TACI syndrome may still achieve a reasonable outcome if early recovery occurs. |
| first_indexed | 2025-11-14T18:12:58Z |
| format | Article |
| id | nottingham-675 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| last_indexed | 2025-11-14T18:12:58Z |
| publishDate | 2007 |
| publisher | Elsevier |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-6752024-08-15T15:13:23Z https://eprints.nottingham.ac.uk/675/ Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) Sprigg, Nikola Gray, Laura J. Bath, Philip M.W. Lindenstrom, Ewa Boysen, Gudrun De Deyn, Peter Paul Friis, Pal Leys, Didier Marttila, Reijo Olsson, Jan-Edwin O'Neill, Desmond Ringelstein, Bernd Introduction: Baseline severity and clinical stroke syndrome (Oxford Community Stroke Project, OCSP) classification are predictors of outcome in stroke. We used data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’ (TAIST) to assess the relationship between stroke severity, early recovery, outcome and OCSP syndrome. Methods: TAIST was a randomised controlled trial assessing the safety and efficacy of tinzaparin versus aspirin in 1,484 patients with acute ischaemic stroke. Severity was measured as the Scandinavian Neurological Stroke Scale (SNSS) at baseline and days 4, 7 and 10, and baseline OCSP clinical classification recorded: total anterior circulation infarct (TACI), partial anterior circulation infarct (PACI), lacunar infarct (LACI) and posterior circulation infarction (POCI). Recovery was calculated as change in SNSS from baseline at day 4 and 10. The relationship between stroke syndrome and SNSS at days 4 and 10, and outcome (modified Rankin scale at 90 days) were assessed. Results: Stroke severity was significantly different between TACI (most severe) and LACI (mildest) at all four time points (p<0.001), with no difference between PACI and POCI. The largest change in SNSS score occurred between baseline and day 4; improvement was least in TACI (median 2 units), compared to other groups (median 3 units) (p<0.001). If SNSS did not improve by day 4, then early recovery and late functional outcome tended to be limited irrespective of clinical syndrome (SNSS, baseline: 31, day 10: 32; mRS, day 90: 4); patients who recovered early tended to continue to improve and had better functional outcome irrespective of syndrome (SNSS, baseline: 35, day 10: 50; mRS, day 90: 2). Conclusions: Although functional outcome is related to baseline clinical syndrome (best with LACI, worst with TACI), patients who improve early have a more favourable functional outcome, irrespective of their OCSP syndrome. Hence, patients with a TACI syndrome may still achieve a reasonable outcome if early recovery occurs. Elsevier 2007-03-15 Article PeerReviewed Sprigg, Nikola, Gray, Laura J., Bath, Philip M.W., Lindenstrom, Ewa, Boysen, Gudrun, De Deyn, Peter Paul, Friis, Pal, Leys, Didier, Marttila, Reijo, Olsson, Jan-Edwin, O'Neill, Desmond and Ringelstein, Bernd (2007) Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Journal of the Neurological Sciences, 254 (1-2). pp. 54-59. ISSN 0022-510X tinzaparin acute ischaemic Stroke http://www.elsevier.com/wps/find/journaldescription.cws_home/506078/description#description |
| spellingShingle | tinzaparin acute ischaemic Stroke Sprigg, Nikola Gray, Laura J. Bath, Philip M.W. Lindenstrom, Ewa Boysen, Gudrun De Deyn, Peter Paul Friis, Pal Leys, Didier Marttila, Reijo Olsson, Jan-Edwin O'Neill, Desmond Ringelstein, Bernd Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) |
| title | Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) |
| title_full | Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) |
| title_fullStr | Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) |
| title_full_unstemmed | Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) |
| title_short | Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) |
| title_sort | stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'tinzaparin in acute ischaemic stroke trial (taist) |
| topic | tinzaparin acute ischaemic Stroke |
| url | https://eprints.nottingham.ac.uk/675/ https://eprints.nottingham.ac.uk/675/ |